USANA Health Sciences NYSE: USNA said its core nutritional business remained in line with expectations during the second quarter of 2026, while near-term challenges at its Hiya and Rise Wellness ventures led the company to lower its full-year outlook.
USANA Health Sciences, Inc. stock fell sharply after Q2 earnings. The direct selling business has continued to shrink at quite a predictable pace. USNA's two growth brands, Hiya and Rise Wellness, showed a concerning performance. Revenues plummeted, and the brands' 2026 guidance was cut massively.
USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript
| Food Products Industry | Consumer Staples Sector | Kevin G. Guest CEO | XFRA Exchange | 90328M107 CUSIP |
| US Country | 1,570 Employees | - Last Dividend | 31 Oct 2003 Last Split | 25 Jul 1996 IPO Date |
USANA Health Sciences, Inc., founded in 1992 and headquartered in Salt Lake City, Utah, is a company specializing in the development, manufacture, and sale of science-based nutritional and personal care products. It leverages scientific research to provide a wide range of high-quality products aimed at improving the nutritional and skincare needs of its customers. With a direct sales model, USANA extends its product offerings to various age groups across the Asia Pacific, the Americas, and Europe, ensuring that its products are readily accessible both in-store and online. The company also engages in notable research collaborations, including with Beijing University of Chinese Medicine and the National Sports Training Bureau, to further enhance its product efficacy and innovation in the field of health and wellness.
USANA Health Sciences, Inc. provides an array of products designed to cater to the nutritional and skincare needs of a diverse clientele. These include: